Concepedia

Goyo Nagai

GN

13

Publications

309

Citations

11

H-Index

2009

Active since

Affiliations

University of the Ryukyus(Current)

Moscow Research and Clinical Center for Neuropsychiatry

Goyo Nagai is an author at University of the Ryukyus specializing in pharmacology, medicine, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2009–2018

13

Publications

13

Effects of Genetic Polymorphisms of CYP2D6, CYP3A5, and ABCB1 on the Steady-State Plasma Concentrations of Aripiprazole and Its Active Metabolite, Dehydroaripiprazole, in Japanese Patients With Schizophrenia

Takeshi Suzuki, Kazuo Mihara, A. Nakamura et al. · Therapeutic Drug Monitoring · 2014 · 57 citations

Effects of the CYP2D6*10 Allele on the Steady-State Plasma Concentrations of Aripiprazole and Its Active Metabolite, Dehydroaripiprazole, in Japanese Patients With Schizophrenia

Takeshi Suzuki, Kazuo Mihara, A. Nakamura et al. · Therapeutic Drug Monitoring · 2010 · 42 citations

, , +19

Pharmacokinetic and Pharmacodynamic Interactions Between Carbamazepine and Aripiprazole in Patients With Schizophrenia

A. Nakamura, Kazuo Mihara, Goyo Nagai et al. · Therapeutic Drug Monitoring · 2009 · 39 citations

, , +19

Relationship Between Plasma Concentrations of Lamotrigine and Its Early Therapeutic Effect of Lamotrigine Augmentation Therapy in Treatment-Resistant Depressive Disorder

Shoko Kagawa, Kazuo Mihara, A. Nakamura et al. · Therapeutic Drug Monitoring · 2014 · 31 citations

Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of<i>dopamine<scp>D</scp>2 receptor</i>and<i>cytochrome<scp>P</scp>450 2<scp>D</scp>6</i>in Japanese patients with schizophrenia

Goyo Nagai, Kazuo Mihara, A. Nakamura et al. · Psychiatry and Clinical Neurosciences · 2012 · 28 citations · Full text

Rows per page

1–5 of 13